Home -> Law Blog Directory -> Litigation Blogs -> How Appealing

Litigation

: How Appealing

"7th Circuit: No Preemption for Failure-to-warn Claims Involving SSRI."

"7th Circuit: No Preemption for Failure-to-warn Claims Involving SSRI." Thompson Publishing Group has a newsbrief that begins, "In one of the most important decisions on the issue of federal preemption of state law tort claims involving a pharmaceutical since the Supreme Court considered the issue in Wyeth v. Levine, 129 S. Ct. 1187 (2009), a federal appeals court has held that failure-to-warn claims brought against the manufacturer of the antidepressant Paxil are not preempted."

You can access today's ruling of a unanimous three-judge ruling of the U.S. Court of Appeals for the Seventh Circuit at this link. Senior Circuit Judge Terence T. Evans wrote the opinion of the court.

The "Drug and Device Law" blog condemns the ruling in a post that you can access here.

Full post as published by How Appealing on February 23, 2010 (boomark / email).